Literature DB >> 840892

Enhancement of the biological activity of adenosine analogs by the adenosine deaminase inhibitor 2'-deoxycoformycin.

R H Adamson, D W Zaharevitz, D G Johns.   

Abstract

The potent adenosine deaminase inhibitor 2'-deoxycoformycin ((R)-3-(2-deoxy-beta-D-erythropentofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol) inhibits the enzymic inactivation and potentiates the cytotoxic activity of a variety of adenosine analogs in the P388 murine leukemia cell culture system. The activity of all seven adenosine analogs examined was enhanced by 2'-deoxycoformycin with the exception of tubercidin (7-deaza-adenosine) which is not a substrate for the deaminase. In vivo, 2'-deoxy-coformycin potentiated the antineoplastic activity of 9-beta-D-xylofuranosyladenine in mice with P388 murine leukemia.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 840892     DOI: 10.1159/000136666

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  10 in total

1.  Physiologic model for the pharmacokinetics of 2'deoxycoformycin in normal and leukemic mice.

Authors:  F G King; R L Dedrick
Journal:  J Pharmacokinet Biopharm       Date:  1981-10

2.  Specific binding of 3H-adenosine to rat brain membranes.

Authors:  U Schwabe; H Kiffe; C Puchstein; T Trost
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

Review 3.  Adenosine deaminase inhibitors: their role in chemotherapy and immunosuppression.

Authors:  R I Glazer
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

4.  Adenosine release from stimulated mast cells.

Authors:  D L Marquardt; H E Gruber; S I Wasserman
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

5.  Effects of adenosine deaminase inhibitor 2'-deoxycoformycin on the repair and expression of potentially lethal damage sensitive to beta-araA.

Authors:  G Iliakis; F Q Ngo
Journal:  Radiat Environ Biophys       Date:  1985       Impact factor: 1.925

6.  Inhibition of adenosine deaminase (ADA)-mediated metabolism of cordycepin by natural substances.

Authors:  Gen Li; Izumi Nakagome; Shuichi Hirono; Tomoo Itoh; Ryoichi Fujiwara
Journal:  Pharmacol Res Perspect       Date:  2015-02-10

7.  Effects of cordycepin on HepG2 and EA.hy926 cells: Potential antiproliferative, antimetastatic and anti-angiogenic effects on hepatocellular carcinoma.

Authors:  Haisheng Lu; Xiting Li; Jianying Zhang; Hui Shi; Xiaofeng Zhu; Xiaoshun He
Journal:  Oncol Lett       Date:  2014-03-11       Impact factor: 2.967

8.  Antiplatelet and antithrombotic effects of cordycepin-enriched WIB-801CE from Cordyceps militaris ex vivo, in vivo, and in vitro.

Authors:  Hyuk-Woo Kwon; Jung-Hae Shin; Deok Hwi Lim; Woo Jeong Ok; Gi Suk Nam; Min Ji Kim; Ho-Kyun Kwon; Jun-Hee Noh; Je-Young Lee; Hyun-Hong Kim; Jong-Lae Kim; Hwa-Jin Park
Journal:  BMC Complement Altern Med       Date:  2016-12-07       Impact factor: 3.659

9.  Cordycepin attenuates Salivary Hypofunction through the Prevention of Oxidative Stress in Human Submandibular Gland Cells.

Authors:  Atchara Jaiboonma; Palakorn Kaokaen; Nipha Chaicharoenaudomrung; Phongsakorn Kunhorm; Kajohnkiart Janebodin; Parinya Noisa; Paiboon Jitprasertwong
Journal:  Int J Med Sci       Date:  2020-07-06       Impact factor: 3.738

10.  Preclinical assessment of the treatment of second-stage African trypanosomiasis with cordycepin and deoxycoformycin.

Authors:  Suman K Vodnala; Marcela Ferella; Hilda Lundén-Miguel; Evans Betha; Nick van Reet; Daniel Ndem Amin; Bo Oberg; Björn Andersson; Krister Kristensson; Hans Wigzell; Martin E Rottenberg
Journal:  PLoS Negl Trop Dis       Date:  2009-08-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.